Rhenman & Partners Asset Management AB - OREXIGEN THERAPEUTICS INC ownership

OREXIGEN THERAPEUTICS INC's ticker is OREXQ and the CUSIP is 686164302. A total of 53 filers reported holding OREXIGEN THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 1.52 and the average weighting 0.0%.

Quarter-by-quarter ownership
Rhenman & Partners Asset Management AB ownership history of OREXIGEN THERAPEUTICS INC
ValueSharesWeighting
Q2 2017$348,000
-15.7%
120,0000.0%0.05%
-23.1%
Q1 2017$413,000
+97.6%
120,0000.0%0.06%
+62.5%
Q4 2016$209,000
-99.9%
120,0000.0%0.04%
-36.5%
Q3 2016$398,400,000120,0000.06%
Other shareholders
OREXIGEN THERAPEUTICS INC shareholders Q1 2017
NameSharesValueWeighting ↓
Foresite Capital Management II, LLC 523,132$1,109,0000.45%
BVF INC/IL 734,976$1,558,0000.20%
Old West Investment Management, LLC 155,302$329,0000.17%
Baupost Group 2,226,839$4,721,0000.06%
Nine Chapters Capital Management LLC 12,500$27,0000.06%
NEA Management Company, LLC 370,900$786,0000.03%
Rock Springs Capital Management LP 165,300$350,0000.02%
JACOBS LEVY EQUITY MANAGEMENT, INC 91,539$194,0000.00%
Virtu Financial LLC 29,699$63,0000.00%
SABBY MANAGEMENT, LLC 19,700$42,0000.00%
View complete list of OREXIGEN THERAPEUTICS INC shareholders